Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.

Journal of Korean Medical Science
Kyubo KimSung W Ha

Abstract

Prognostic value of p53 and bcl-2 expression on treatment outcome in breast cancer patients has been extensively evaluated, but the results were inconclusive. We evaluated the prognostic significance of these molecular markers in patients treated with breast conserving surgery and radiotherapy. One hundred patients whose immunostaining of p53 and bcl-2 expression was available among 125 patients who underwent radiotherapy after breast conserving surgery and axillary lymph node dissection were enrolled into this study. Eighty-seven patients also received adjuvant chemotherapy and/or hormonal therapy. Conventional clinicopathologic variables and treatment-related factors were also considered. The 5-yr loco-regional relapse-free and distant metastasis-free survival rates were 91.7% and 90.9%, respectively. On univariate analysis, age, T stage and the absence of bcl-2 & estrogen receptor (ER) expression were associated with loco-regional relapse-free survival. When incorporating these variables into Cox proportional hazard model, only bcl-2(-)/ER(-) phenotype was an adverse prognostic factor (P=0.018). As for the distant metastasis-free survival, age, T stage, and p53 expression were significant on univariate analysis. However, p53...Continue Reading

References

Jun 3, 1992·Journal of the National Cancer Institute·A D ThorB H Mayall
Aug 1, 1995·British Journal of Cancer·P HellemansE Van Marck
Apr 7, 1998·Cancer·M D BerardoD C Allred
Sep 25, 2001·The Journal of Pathology·A A AlizadehM van de Rijn
Nov 25, 2004·The Oncologist·Mary Cianfrocca, Lori J Goldstein
Mar 17, 2006·Breast Cancer Research and Treatment·Alessandro NeriEnrico Pinto
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Grace M CallagyCarlos Caldas
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce G HafftyDeborah Toppmeyer
Dec 6, 2006·Cancer·Emad A RakhaIan O Ellis
Dec 26, 2006·International Journal of Cancer. Journal International Du Cancer·Phil RollandLindy Durrant
Oct 9, 2007·Breast Cancer Research and Treatment·David S P TanJorge S Reis-Filho
Mar 8, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F-C BidardF Penault-Llorca
Apr 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul L NguyenJay R Harris

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

SPSS

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.